Our use of cookies

We use necessary cookies to make our site work.

For more detailed information about the cookies we use, see our Cookie Policy.


Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Global Operations

Our Global Mission: Otsuka-people creating new products for better health worldwide

At Otsuka our people are passionate about developing and delivering products as part of our global commitment to better health and wellbeing. We have two core businesses dedicated to achieving our goals: a pharmaceutical business and a nutraceutical business. Our pharmaceutical business develops and markets products for the diagnosis and treatment of disease in the following areas: neuroscience, nephrology, haemato-oncology, endocrinology, cardiovascular, renal, ophthalmology and infectious disease. Our nutraceutical business is dedicated to maintaining and improving health through the use of foods and beverages that provide extra health benefits. Since our beginning, nearly 100 years ago, the Otsuka family has sought to travel down the paths of discovery where others are less likely to tread. We endeavour to adhere to the highest applicable standards in how we develop and deliver our products and in how we treat our most valuable assets, our people.

Otsuka Holdings - Core Business Areas*

Pharmaceuticals:
  • Pharmaceuticals
  • Clinical nutrition
  • Diagnostics
  • Medical devices
Nutraceutical:
  • Functional foods & beverages
  • Cosmedics (cosmetic + medicine)
  • OTC products
Consumer:
  • Beverages
  • Foods
Other:
  • Functional chemicals
  • Fine chemicals
  • Distribution
  • Packaging
  • Electronic equipment
*Core business area values based on total 2022 revenue

Date of preparation: June 2023 | Reference NOR-NPR-2300004

This website is for all those with an interest in Otsuka Pharmaceutical in the Nordics and BeNeLux.